ITGA1 and neoplasm: As demonstrated in the skin, transfer of TRMs from immune to naive hosts is sufficient to prevent HSV type 1 (HSV-1)-associated pathology, and comparably, the presence of Ag-specific CD49a+CD103+ TILs in a mouse model of melanoma can limit tumor growth (1, 2).